92 related articles for article (PubMed ID: 11937175)
1. Angiotensin blockade for hypertension: a promise fulfilled.
Brunner HR; Gavras H
Lancet; 2002 Mar; 359(9311):990-2. PubMed ID: 11937175
[No Abstract] [Full Text] [Related]
2. [Angiotensin1-receptor antagonist losartan. Part I. Basic clinical pharmacology].
Sidorenko BA; Preobrazhenskiĭ DV; Stetsenko TM; Malysheva NV; Tsurko VV; Tarykina EV
Kardiologiia; 2003; 43(1):90-8. PubMed ID: 12891291
[TBL] [Abstract][Full Text] [Related]
3. Comparison of losartan and captopril in ELITE II.
Meyer FP
Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947
[No Abstract] [Full Text] [Related]
4. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
Traut
Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
[No Abstract] [Full Text] [Related]
5. [Losartan potassium, an angiotensin II receptor antagonist].
Yoshinaga K
Nihon Rinsho; 2000 Feb; 58 Suppl 2():140-3. PubMed ID: 11028309
[No Abstract] [Full Text] [Related]
6. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
Nattel S
Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
[No Abstract] [Full Text] [Related]
7. [Comparison with other antihypertensive drugs, especially with ACEI].
Hiwada K
Nihon Rinsho; 1999 May; 57(5):1187-93. PubMed ID: 10361454
[TBL] [Abstract][Full Text] [Related]
8. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
Hunyady L; Nagy L
Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
[TBL] [Abstract][Full Text] [Related]
9. [Angiotensin receptor antagonist for therapy of patients with hypertension].
Rakugi H; Ogihara T
Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
[TBL] [Abstract][Full Text] [Related]
10. LIFE: losartan versus atenolol.
Chong AY; Lip GY
Lancet; 2003 Oct; 362(9393):1416. PubMed ID: 14585648
[No Abstract] [Full Text] [Related]
11. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
Andersson OK; Neldam S
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
[No Abstract] [Full Text] [Related]
12. Losartan and renal transplantation.
Horn S; Holzer H; Horina J
Lancet; 1998 Jan; 351(9096):111. PubMed ID: 9439500
[No Abstract] [Full Text] [Related]
13. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
Baumgart P
MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
[No Abstract] [Full Text] [Related]
14. [New therapeutic principle in the management of cardiac insufficiency: A II antagonists. Results of the ELITE study (Evaluation of Losartan In The Elderly)].
Dtsch Med Wochenschr; 1997 Sep; 122(39 Suppl):1-4. PubMed ID: 9351465
[No Abstract] [Full Text] [Related]
15. [Hypertension in patients with cardiac hypertrophy].
Kohno M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
[No Abstract] [Full Text] [Related]
16. Losartan decreased premature ventricular contractions in patients with hypertension.
Shiraishi H; Shirayama T; Sakamoto T; Kuroyanagi A; Matsubara H
J Hum Hypertens; 2009 Apr; 23(4):289-91. PubMed ID: 18843280
[TBL] [Abstract][Full Text] [Related]
17. [ACE inhibitors or AT1 receptor antagonists?].
Riegger GA
Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
[No Abstract] [Full Text] [Related]
18. Fetal toxic effects and angiotensin-II-receptor antagonists.
Martinovic J; Benachi A; Laurent N; Daikha-Dahmane F; Gubler MC
Lancet; 2001 Jul; 358(9277):241-2. PubMed ID: 11480433
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
[TBL] [Abstract][Full Text] [Related]
20. [Angiotensin II receptor antagonists: a review of the development and future perspective].
Saito I; Saruta T
Nihon Rinsho; 1999 May; 57(5):1015-9. PubMed ID: 10361427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
